Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (181-190 of 652) with videos related to

Pageof 66
Sort By:
Nutrients|November 17, 2018
Cross-Sectional Analysis of Overall Dietary Intake and Mediterranean Dietary Pattern in Patients with Crohn's DiseaseLorian Taylor, Abdulelah Almutairdi, Nusrat Shommu, et al.
Journal of Crohn'S & Colitis|June 9, 2025
Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial dataJulian Panés, Marla C Dubinsky, Yoh Ishiguro, et al.
Inflammatory Bowel Diseases|May 14, 2013
52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressantsWalter Reinisch, William J Sandborn, Remo Panaccione, et al.
Nature Reviews. Gastroenterology & Hepatology|October 8, 2024
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel diseaseChristopher Ma, Vipul Jairath, Brian G Feagan, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|December 18, 2001
Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomicsB G Feagan, R Enns, R N Fedorak, et al.
Journal of Chemical Ecology|July 10, 2013
Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae)Wesley T Beaulieu, Daniel G Panaccione, Corey S Hazekamp, et al.
Child Abuse & Neglect|March 20, 2024
Childhood sexual abuse and suicide attempts in patients with substance use disorders: The mediating role of emotion dysregulationMarco Di Nicola, Maria Pepe, Silvia Montanari, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysisSiddharth Singh, M Hassan Murad, Mathurin Fumery, et al.
BMC Gastroenterology|December 23, 2016
Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease durationM Ellen Kuenzig, Sang Min Lee, Bertus Eksteen, et al.
Idcases|September 2, 2024
<i>Escherichia coli ST1193 O75 H5</i>: A rare cause of native valve endocarditis with multifocal emboli to brain and spleenDiana M Villanueva, John R Lonks, Sara Geffert, et al.
Pageof 66

Showing results (181-190 of 652) with videos related to

Sort By:
Pageof 66
Nutrients|November 17, 2018
Cross-Sectional Analysis of Overall Dietary Intake and Mediterranean Dietary Pattern in Patients with Crohn's DiseaseLorian Taylor, Abdulelah Almutairdi, Nusrat Shommu, et al.
Journal of Crohn'S & Colitis|June 9, 2025
Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial dataJulian Panés, Marla C Dubinsky, Yoh Ishiguro, et al.
Inflammatory Bowel Diseases|May 14, 2013
52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressantsWalter Reinisch, William J Sandborn, Remo Panaccione, et al.
Nature Reviews. Gastroenterology & Hepatology|October 8, 2024
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel diseaseChristopher Ma, Vipul Jairath, Brian G Feagan, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|December 18, 2001
Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomicsB G Feagan, R Enns, R N Fedorak, et al.
Journal of Chemical Ecology|July 10, 2013
Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae)Wesley T Beaulieu, Daniel G Panaccione, Corey S Hazekamp, et al.
Child Abuse & Neglect|March 20, 2024
Childhood sexual abuse and suicide attempts in patients with substance use disorders: The mediating role of emotion dysregulationMarco Di Nicola, Maria Pepe, Silvia Montanari, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysisSiddharth Singh, M Hassan Murad, Mathurin Fumery, et al.
BMC Gastroenterology|December 23, 2016
Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease durationM Ellen Kuenzig, Sang Min Lee, Bertus Eksteen, et al.
Idcases|September 2, 2024
<i>Escherichia coli ST1193 O75 H5</i>: A rare cause of native valve endocarditis with multifocal emboli to brain and spleenDiana M Villanueva, John R Lonks, Sara Geffert, et al.
Pageof 66